May 15, 2018

LaidLaw List of Alternative Investments and Common Stock Sales

business man holding his head with text asking questions about stock broker misconduct

Alternative Investment Strategies Can Be Costly To Investors and Enrich Brokers

Soreide Law Group recently filed a  FINRA arbitration for a customer of Laidlaw & Company for losses in several offerings where the firm is advertising through their website that they were the underwriter of the investments.  The offerings at issue are contained in the list below but there are many offerings that that they are the underwriter of that investors may own that may be performing poorly or not performing as promised.  Some investments below may not have gone down in value, but many alternative investments in this list have. Here is a list of investments LaidLaw & Company is advertising that they were the underwriter of through their investment banking business.
AirLift Investments, LLC
Private-I Partners, LLC
T-Bird Partners, LLC
Bionic Partners, LLC
Shire Investments, LLC
Bluebird Investment Partners
Pre-Game Partners, LLC
Pre-Flight Partners, LLC
Pre-Market Partners, LLC
Social T Partners, LLC
Face-Off Partners II, LLC
Chain-Link Partners, LLC
Face-Off Partners, LLC
Below is a list of common stock offerings that may or may not have declined in value, but many investors who own these could have other investments that lost money:
MEI Pharma
Eleven Biotherapeutics
AIT Therapeutics
Hoth Therapeutics
Affimed (Affi Med)
Gemphire
Athenex, Inc.
Fennec Pharmaceuticals
Cytori Therapeutics
ADMA Biologics
Onconova Therapeutics
Asterias Biotherapeutics
Flexion Therapeutics
Aldeyra Therapeutics
MabVax Therapeutics, Inc.
Repros Therapeutics
Biosig Technologies
Therapix Biosciences
Alliqua
Actinium Pharmaceuticals, Inc.
Relmada Therapeutics
Boston Therapeutics
Cyclacel Pharmaceuticals
NovaBay Pharmaceuticals
Protea Biosciences Group, Inc.
Cel-Sci Corporation
If you invested in any of the aforementioned investments call the securities lawyers at Soreide Law Group for a free consultation to see if you may have a potential claims against Laidlaw & Company for selling unsuitable investments. Call (888) 760-6552.

S H A R E   T H I S   P O S T

Recent Posts

September 13, 2026
James Tighe Of Morgan Stanley Barred By FINRA After Investigation

Investors might have sustained losses due to securities broker James Fredrick Tighe [CRD: 3129233, Phoenix, Arizona], and Financial Industry Regulatory Authority barred him, based on public information on BrokerCheck. Tighe was associated with Morgan Stanley from June 1, 2009, through January 14, 2025. Continue reading to find out more about Tighe’s regulatory and client dispute […]

September 13, 2026
Sung Cho Of Citigroup Global Markets Barred By FINRA Following Investigation

Investors potentially experienced sales practice violations by securities broker Sung Moo Cho (also known as Sam Cho) [CRD: 5015906, New York, New York], and FINRA barred him, given the public information found on FINRA BrokerCheck. Cho was associated with Ameriprise Financial Services from January 22, 2021, to October 21, 2025, and Citigroup Global Markets from […]

September 13, 2026
Raymond Brown Of Northwestern Mutual Barred By FINRA For Failure To Testify

Investors potentially incurred losses because of securities broker Raymond Trey Brown [CRD: 6170291, Frisco, Texas], and FINRA sanctioned him, according to disclosures on FINRA BrokerCheck. Brown worked for Northwestern Mutual Investment Services LLC, from March 17, 2014, to December 13, 2024. See below to learn more about Brown’s disclosures. FINRA Sanctioned Raymond Brown For Failure […]

Contact us Nationwide USA
2401 E. Atlantic Blvd., Suite 305, Pompano Beach, FL 33062
Helping clients recover money across the USA
search
Copyright © 2025 Soreide Law Group, PLLC  |  All Rights Reserved